Fundz

Exscientia Completes $100 million Series C Financing Round With BlackRock Funds

Mar 04, 2021

Amount Raised

$100 Million

Round Type

Series C

OxfordBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence

Description

Exscientia, a clinical stage pharmatech pioneering the use of artificial intelligence (AI) to design new drugs, today announced that funds managed by BlackRock joined the Company’s Series C investment round. Including existing Series C investors, Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital, the round totalled $100 million in funding.

Quick answer

Exscientia raised $100 Million in a Series C round, dated March 4, 2021. Exscientia is based in Oxford, Mississippi, United States.

How much did Exscientia raise?
Exscientia raised $100 Million in a Series C round on March 4, 2021.
What does Exscientia do?
Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner.
Where is Exscientia based and how big is it?
Exscientia is based in Oxford, Mississippi, United States. Fundz records about 455 employees.

Source: Fundz verified event record.

Who to call at Exscientia, and when

A new round usually means Exscientia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Exscientia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Exscientia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Exscientia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Exscientia

Location

Oxford, Mississippi, United States

About

Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Exscientia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Exscientia's next move

See what Strategic adds

Exscientia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.